From a New Atlas online article (Jan 1, 2020):
“This is an entirely new approach with no current treatments able to change scar in this way,” says Associate Professor James Chong who led the research. “By improving cardiac function and scar formation following heart attack, treatment with rhPDGF-AB led to an overall increase in survival rate in our study.”
The research centers on a protein therapy called recombinant human platelet-derived growth factor-AB (rhPDGF-AB), which had previously been shown to improve heart function in mice that had suffered a heart attack. In a new study aimed at bringing the treatment closer to human trials, a team set out to discover if it produced similar results in large animals, namely pigs.
The researchers from the Westmead Institute for Medical Research (WIMR) and the University of Sydney found that when pigs that had suffered a heart attack received an infusion of rhPDGF, it did indeed prompt the formation of new blood vessels in the heart and led to a reduction of potentially fatal heart arrhythmia.



At the moment, about two-thirds of Americans do not meet the standard exercise guidelines of about 30 minutes a day of moderate exercise, such as walking.
surgery, chemotherapy and radiation. We spend $150 billion each year treating cancer, yet a patient with cancer is as likely to die of it today — with a few exceptions — as one was 50 years ago. Today we spend the hour with renowned cancer doctor, Dr. Azra Raza, author of the new book, “The First Cell: And the Human Costs of Pursuing Cancer to the Last.” She argues that experiments and the funding for eradicating cancer look at the disease when it is in its later stages, when the cancer has grown and spread. Instead, she says, the focus should be on the very first stages — the first cell, as her book is titled. She says this type of treatment would be more effective, cheaper and less toxic.
…the researchers demonstrated that the biggest drop in cognitive ability occurs at the slightest level of hearing loss — a decline from zero to the “normal” level of 25 decibels, with smaller cognitive losses occurring when hearing deficits rise from 25 to 50 decibels.
cardiovascular events.


